Symtuza and Biktarvy Will Join Other Combos for Treating HIV

June 2018

Symtuza (sim-TOO-zah) and Biktarvy (bik-TAR-vee) will be the latest first-line treatments for HIV.

Think of each of these as a complete HIV regimen in one pill.

Symtuza is a combination of Prezcobix (darunavir/cobicistat) and Descovy (emtricitabine/tenofovir alafenamide).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Medication Errors Minimize Risk When Using Quick Codes
Vaccines Ensure Your Pharmacy Stores and Uses Diluents Properly
Med Administration Help Your Patients Take Their Meds at the Right Time
Naloxone Streamline Processes for Dispensing Naloxone
Diabetes Help Ensure Patients Get the Most From Their Diabetes Meds
Vaccines Identify Pregnant Women Who Need the Tdap Vaccine
HIV & AIDS Symtuza and Biktarvy Will Join Other Combos for Treating HIV
Antithrombotics Know How Anticoagulants and Antiplatelets Compare
Depression Watch for Teens Who Have or Are at Risk for Depression
Diabetes Don't Expect All Diabetes Patients to Regularly Monitor Blood Sugar